Skip to Content
  • Previous Rank
    176
  • Revenues ($M)
    15,879
  • Revenue Percent Change
    -3.1%
  • Profits ($M)
    2,004
  • Profits Percent Change
    -21.8%
  • Market Value (as of March 31, 2015)
    107,500

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Company Info

CEO
Giovanni Caforio
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
New York, NY
Websitehttp://www.bms.com
Years on List21
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)15,879-3.1%
Profits ($M)2,004-21.8%
Total Stockholder Equity14,852-
Employees25,000-
Market Value (as of March 31, 2015)107,500-

Profit Ratios

Profit as % of Revenues12.6%
Profits as % of Assets5.9%
Profits as % of Stockholder Equity13.5%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)1.2
EPS % Change (from 2013)-22.1%
EPS % Change (5 year annual rate)-25.8%
EPS % Change (10 year annual rate)-0.1%

Total Return

Total Return to Investors (2014)14.2%
Total Return to Investors (5 year, annualized)23.3%
Total Return to Investors (10 year, annualized)13.6%